COSMO Pharmaceuticals SA Share Price Swiss Exchange
Equities
LU1202320294
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
|
Sales 2024 * | 264M 284M 255M 22.39B | Sales 2025 * | 242M 260M 234M 20.55B | Capitalization | 1.17B 1.26B 1.13B 99.28B |
---|---|---|---|---|---|
Net income 2024 * | 124M 133M 120M 10.53B | Net income 2025 * | 76M 81.8M 73.62M 6.46B | EV / Sales 2024 * | 3.98 x |
Net cash position 2024 * | 120M 129M 116M 10.15B | Net cash position 2025 * | 210M 226M 204M 17.87B | EV / Sales 2025 * | 3.96 x |
P/E ratio 2024 * |
9.5
x | P/E ratio 2025 * |
12.8
x | Employees | - |
Yield 2024 * |
2.88% | Yield 2025 * |
1.06% | Free-Float | 44.36% |
Latest transcript on COSMO Pharmaceuticals SA
Managers | Title | Age | Since |
---|---|---|---|
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 31/05/16 |
Chairman | 61 | 31/12/05 | |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 69 | 31/12/96 | |
Director/Board Member | 69 | 31/03/12 | |
Chairman | 61 | 31/12/05 |
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
+43.36% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.09% | 242B | |
+2.09% | 224B | |
+13.16% | 218B | |
+8.48% | 168B |